Abstract
An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 305-313 |
| Number of pages | 9 |
| Journal | Mental Retardation and Developmental Disabilities Research Reviews |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1999 |
| Externally published | Yes |
Fingerprint
Keywords
- ADHD
- Angelman syndrome
- Fetal alcohol syndrome
- Fragile X syndrome
- Mental retardation
- Prader-Willi syndrome
- Psychopharmacology
- Smith-Magenis syndrome
- Stimulants
- Velocardiofacial syndrome
- Williams syndrome
ASJC Scopus subject areas
- Genetics(clinical)
- Pediatrics, Perinatology, and Child Health
- Neuropsychology and Physiological Psychology
Cite this
Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome. / Hagerman, Randi J.
In: Mental Retardation and Developmental Disabilities Research Reviews, Vol. 5, No. 4, 1999, p. 305-313.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Psychopharmacological interventions in fragile X syndrome, fetal alcohol syndrome, Prader-Willi syndrome, Angelman syndrome, Smith Magenis syndrome, and velocardiofacial syndrome
AU - Hagerman, Randi J
PY - 1999
Y1 - 1999
N2 - An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.
AB - An overview of psychopharmacological interventions in developmental disorders is presented, followed by a review of treatment in fragile X syndrome, fetal alcohol syndrome, Angelman syndrome, Prader-Willi syndrome, Smith-Magenis syndrome, and velocardiofacial syndrome. Each of these disorders has a specific behavioral phenotype, and we are making progress in clarifying each of their psychopharmacological phenotypes. Common problems such as attention deficit hyperactivity disorder and mood lability are reviewed, although unique aspects of each disorder are emphasized.
KW - ADHD
KW - Angelman syndrome
KW - Fetal alcohol syndrome
KW - Fragile X syndrome
KW - Mental retardation
KW - Prader-Willi syndrome
KW - Psychopharmacology
KW - Smith-Magenis syndrome
KW - Stimulants
KW - Velocardiofacial syndrome
KW - Williams syndrome
UR - http://www.scopus.com/inward/record.url?scp=0033373434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033373434&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L
DO - 10.1002/(SICI)1098-2779(1999)5:4<305::AID-MRDD8>3.0.CO;2-L
M3 - Article
VL - 5
SP - 305
EP - 313
JO - Mental Retardation and Developmental Disabilities Research Reviews
JF - Mental Retardation and Developmental Disabilities Research Reviews
SN - 1080-4013
IS - 4
ER -